Grant Pickering - 18 Jun 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: PCVX
Reported as of: 18 Jun 2026
Net transaction value: -$1,284,205
SEC form: 4
Accepted by SEC: 18 Jun 2026, 20:08:15 UTC
Prior SEC filing: 13 Apr 2026
Next SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Grant Pickering filed Form 4 for Vaxcyte, Inc. (PCVX) on 18 Jun 2026.

Key facts

This page summarizes Grant Pickering's Form 4 filing for Vaxcyte, Inc. (PCVX).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2026, 20:08.

Change

Previous filing in this sequence was filed on 13 Apr 2026.
Current net transaction value: -$1,284,205.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258693 Primary reporting owner

PICKERING GRANT

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Options Exercise

Transaction value
Shares: +225
Change %: +0.05%
Price: $1.79^*
Shares after: 497,164
Date: 18 Jun 2026
Ownership: Direct

PCVX transaction

Common Stock

Sale

Transaction value: $11,815
Shares: -225
Change %: -0.05%
Price: $52.51
Shares after: 496,939
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

PCVX transaction

Common Stock

Sale

Transaction value: $1,167,390
Shares: -22,236
Change %: -4.5%
Price: $52.50
Shares after: 474,703
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

PCVX transaction

Common Stock

Sale

Transaction value: $52,500
Shares: -1,000
Change %: -0.73%
Price: $52.50
Shares after: 135,215
Date: 18 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F2

PCVX transaction

Common Stock

Sale

Transaction value: $52,500
Shares: -1,000
Change %: -0.73%
Price: $52.50
Shares after: 135,215
Date: 18 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -225
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 225
Exercise price: $1.79
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.

Footnote F2

Shares are held directly by a trust for the benefit of the Reporting Person's son.

Footnote F3

Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

Footnote F4

Option is fully vested and exercisable.